3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
2
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Flow Cytometry
36
Gene Expression Profiling
34
Surveys and Questionnaires
27
Polymerase Chain Reaction
24
Microarray Analysis
23
Blood Specimen Collection
19
Interviews as Topic
18
Imatinib Mesylate
15
Amplified Fragment Length Polymorphism Analysis
14
Reverse Transcriptase Polymerase Chain Reaction
13
Cytogenetic Analysis
13
Rituximab
12
venetoclax
11
nilotinib
10
Psychiatric Rehabilitation
10
Dasatinib
10
Immunologic Techniques
9
DNA Methylation
9
Blotting, Western
9
ponatinib
8
Watchful Waiting
8
Observation
8
In Situ Hybridization, Fluorescence
8
Base Sequence
8
Azacitidine
8
ibrutinib
7
fludarabine
7
bosutinib
7
Therapeutics
7
Specimen Handling
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Diagnostic Tests, Routine
×
Other hematologic neoplasm
×
Clear all
NCT05645133
2023-06-15
QPlus Pediatric Reference Interval
HemoSonics LLC
Terminated
93 enrolled